Issue of Equity

RNS Number : 2369C

Integumen PLC

11 April 2017

 

Integumen plc

11 April 2017

Issue of Equity

Integumen plc (AIM: SKIN), the personal health care company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes, announces that it has today issued 800,000 new ordinary shares of 1p each at an issue price of 5p per ordinary share ("Ordinary Shares").

These shares have been issued as follows:

(i) 300,000 Ordinary Shares to Gunsynd plc ("Gunsynd") as part of an arrangement with Gunsynd that Gunsynd will waive all claims, demands and/or rights of action of any kind it may have against the Company's subsidiary, Innovenn Limited ("Innovenn"), arising under or in connection with certain provisions of an asset purchase agreement, further details of which are set out in paragraph 13 (xxv) of Part V of the Company's Admission Document dated 30 March 2017, and will release and discharge Innovenn from all and any liability in respect of such claims, demands and/or rights of action. This includes a waiver of the obligation to make a cash payment to Gunsynd equal to 25 per cent. of any consideration, royalty or other payment received in relation to the sale or licence of intellectual property which relates to SYN1113 (also described in paragraph 13 (xxv) of Part V of the Company's Admission Document dated 30 March 2017).

(ii) 500,000 Ordinary Shares issued in lieu of fees due to one of the Company's professional advisers.

Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence in the Shares on or around 19 April 2017.

In conformity with the Disclosure Guidance and Transparency Rules, the Company notifies the market of the following:

The Company's issued share capital consists of 165,860,248 Ordinary Shares with one voting right each. The Company does not hold any shares in Treasury.  Therefore, the total number of voting rights in the Company is 165,860,248.

The above figure of 165,860,428 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Integumen plc	Declan Service, CEO	+ 353 (0) 87 770 5506
SPARK Advisory Partners Limited (Nominated Adviser)	Neil Baldwin/Sean Wyndham-Quin/Vassil Kirtchev	[phone]
Turner Pope Investments (TPI) Ltd	Ben Turner/James Pope	[phone]
Cardew Group	Shan Shan Willenbrock David Roach	[phone] [e-mail]

 

END

 

 

IOEGGUBCCUPMGCG